Generation of a potentially immunosuppressive rat interleukin-2 immunoglobulin M fusion molecule
Parker, K.E.; Cuturi, M.C.; Soulillou, J.P.
Transplantation Proceedings 25(1 Part 1): 774-775
1993
ISSN/ISBN: 0041-1345 PMID: 8438476 Document Number: 412614
Document emailed within 1 workday
Related Documents
Fais, S.; Burgio, V.L.; Silvestri, M.; Capobianchi, M.R.; Pacchiarotti, A.; Pallone, F. 1994: Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation Laboratory Investigation; a Journal of Technical Methods and Pathology 71(5): 737-744Sakamoto, H.; Sakamaki, T.; Kanda, T.; Hirao, Y.; Ohyama, Y.; Ogishi, K.; Negishi, M.; Masuda, H.; Sumino, H.; Sawada, Y.; Ono, Z.; Kobayashi, I.; Nagai, R. 1997: Immunosuppressive drugs inhibit the production of interleukin-6 and interleukin-8 in cultured cardiac myxoma cells Research Communications in Molecular Pathology and Pharmacology 97(1): 60-66
Yang, J.-h.; Fan, R.-f.; Qian, Q.-j.; You, T.-g.; Xue, H.-b.; Su, C.-q.; Cao, H.-f.; Wu, M.-c. 2003: Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study Zhonghua Yi Xue Za Zhi 83(9): 740-743
Bretscher, P.A.; Ogunremi, O.; Menon, J.N. 1997: Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states Behring Institute Mitteilungen 1997(98): 153-159
Khalil, H.M.; Abd el Baki, M.H.; Abd el Mawla, M.M.; Maklad, K.M.; Sharaf, S.A.; Saad, A.E. 1999: Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy Journal of the Egyptian Society of Parasitology 29(2): 395-408
Indrová, M.; Jandlová, T.; Bubeník, J. 1992: Interaction of interleukin 2 and interleukin 4 during LAK cell generation Folia Biologica 38(1): 1-9
Sutherland, J. 1998: The immunoglobulin molecule Immunohematology 14(1): 12-18
Higashi, Y. 2014: JAK inhibitors as a new generation of small-molecule immunosuppressants Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 144(4): 160-166
Klein, J.R.; Bevan, M.J. 1983: Secretion of immune interferon and generation of cytotoxic T cell activity in nude mice are dependent on interleukin 2: age-associated endogenous production of interleukin 2 in nude mice Journal of Immunology 130(4): 1780-1783
Wasik, M. 1978: Immunosuppressive effect of concanavalin-A. I. Suppression of generation of cytotoxic lymphocytes in MLC Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 327-330
Bell, R.G.; Stephens, C.J.; Turner, K.J. 1974: Marsupial immunoglobulins: an immunoglobulin molecule resembling eutherian IgA in serum and secretions of Setonix brachyurus (quokka) Journal of Immunology 113(1): 371-378
Direskeneli, H.; Ozdogan, H.; Korkmaz, C.; Akoglu, T.; Yazici, H. 1999: Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever Journal of Rheumatology 26(9): 1983-1986
Engel, W.K. 2003: Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome Acta Myologica: Myopathies and Cardiomyopathies: Official Journal of the Mediterranean Society of Myology 22(3): 97-103
Towiwat, P.; Buttham, B. 2017: A Study of Interleukin-2 Production and Nck Adaptor Molecule Gene Expression in Systemic Lupus Erythematosus Patients Journal of the Medical Association of Thailand 100(4): 396-402
Moskaleva, E.S.; Katysheva, O.V.; Ruzhitskaia, E.A.; Nevstrueva, V.V.; Ivanina, E.K.; Ignatova, M.S. 1999: Effect of human immunoglobulin preparation in resistance to immunosuppressive therapy in a male patient with nephrotic syndrome Terapevticheskii Arkhiv 71(6): 75-76
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Murakami, K.; Nakamura, H. 1976: Flexible structure of immunoglobulin G molecule. Fluorescence depolarization studies on hapten-antihapten antibody interactions using arylnaphthalenesulfonates as the ligands Japanese Journal of Experimental Medicine 46(1): 59-70
Elhofy, A.; Bost, K.L. 1998: Limitations for purification of murine interleukin-18 when expressed as a fusion protein containing the FLAG peptide Biotechniques 25(3): 426-433
Vie, H.; Gauthier, T.; Breathnach, R.; Bonneville, M.; Godard, A.; Dietrich, J.; Karam, G.; Gesnel, M.C.; Peyrat, M.A.; Jacques, Y. 1993: Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor Transplantation Proceedings 25(1 Part 1): 741-742
vanderSpek, J.C.; Sutherland, J.; Sampson, E.; Murphy, J.R. 1995: Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15 Protein Engineering 8(12): 1317-1321